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Introduction: Through systematic data review and expert consensus, the AUA (American Uro-
logical Association) produces clinical practice guidelines that serve to provide evidence-based
guidance with an explicit clinical scope and purpose. In this study we determined whether urolo-
gists use clinical practice guidelines when making clinical decisions, and whether demographic
factors are associated with not using the guidelines or with a lack of guideline awareness.
Methods:We examined the 2014 AUA Census. Our outcome was a question regarding whether the
participant used AUA clinical practice guidelines in clinical decision making. We performed
comparative statistical analyses, stratifying our outcome by demographic and practice speciﬁc
variables.
Results: A total of 2,204 urologists completed the census, representing 18.9% of practicing
urologists in the United States. Median age was 53 years and 91.1% were male. The majority of
urologists used clinical practice guidelines (94.8%) in clinical decision making. Clinical practice
guidelines had the lowest use among urologists 65 years old or older (89.2%), those in solo practice
(88.3%) and pediatric specialists (87.9%). Based on a multivariable logistic regression analysis,
factors associated with not using clinical practice guidelines included increasing age, metropolitan
practice setting and solo practice. Gender, AUA section, level of rurality and fellowship training
were not statistically associated with clinical practice guideline use.
Conclusions: The majority of urologists (approximately 95%) use AUA clinical practice guidelines
to inform clinical decisions. Our ﬁndings support the importance of clinical practice guidelines and
highlight potential opportunities for better targeted outreach to improve clinical practice guideline
use among practicing urologists.
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463Clinical Practice Guideline UseClinical practice guidelines provide recommendations for
clinicians to manage speciﬁc conditions and to optimize
patient care.1 CPG recommendations are produced through a
systematic review of the available evidence, and a structured
assessment of the beneﬁts, risks and burdens of care.2 CPGs
undergo rigorous review, are endorsed by national and
international organizations and are circulated widely.3 They
serve to inform clinicians on the best scientiﬁc evidence in
order to reduce inappropriate variation in practice, promote
efﬁciency, provide a continuing update on optimal medical
care and highlight knowledge gaps in the literature. The
sheer volume and speed in the growth of medical literature
compel most clinicians to be familiar with and use CPGs.
The importance of the guidelines for the clinician is further
solidiﬁed as CPG content is being used for board certiﬁca-
tion and recertiﬁcation questions. Hospital administrators,
insurance companies and government agencies have
increasingly used CPG adherence as part of pay-for-
performance or quality metrics, although CPGs are not
speciﬁcally designed for this purpose.4 Furthermore, law-
yers examine CPG adherence when investigating medical
malpractice.5 Clinicians will be increasingly expected to be
familiar with and to use CPGs.6
The AUA has been supporting and organizing the crea-
tion of CPGs since 1994 with the production of the staghorn
calculi guidelines.7 AUA CPGs are consistent with the
rapidly evolving science of clinical guideline development.
The process begins with the development of speciﬁc
research questions based on the patient, intervention,
comparator and outcomes. Using a systematic literature
review, data extraction, analysis and synthesis, an evidence
report is created and ultimately used to develop the ﬁnal
guideline statements. To ensure that AUA CPGs are current
with the literature, an updated literature review is performed
on each guideline using a systematic review, methodologist
and expert panel according to an AUA approved schedule.
A recommendation is then developed that the CPG remains
current, needs minor revision or needs full revision. The
topic prioritization schema developed for new guidelines
provides a numeric value based on several factors, including
the topic importance to urologists, the current status of the
existing peer reviewed literature as well as the existing CPG,
the need to improve entry level education or to synthesize
new high level evidence that would likely impact standard
management regarding the topic.
Previous research has shown variable clinical adherence
with published AUA CPGs.8,9 However, little is known
regarding the self-reported use of AUA CPGs by AUA
members. Understanding CPG use could inform future
dissemination efforts and allow targeted promotion to sub-
populations of urologists. Our objective was to determinewhat demographics are associated with CPG awareness and
use in clinical practice. We hypothesized that physician
demographics such as age and practice location are associ-
ated with CPG use and awareness.Methods and MaterialsStudy PopulationWe analyzed data from the 2014 AUA Census. The census
is a specialty-wide survey disseminated to the global urol-
ogy community including the U.S.10 The 2014 AUA Census
was collected from May 2014 to September 2014 and
contains demographic and practice characteristics. The
2,204 U.S. census respondents represent 11,703 practicing
urologists in the U.S as deﬁned by the National Provider
Identiﬁer.10 Census samples were weighted based on post-
stratiﬁcation factors (ie gender, location and years since
initial certiﬁcation) to adjust for the representation of each
respondent by assigned proper sample weight.10 The cor-
responding author’s institutional review board gave the
study exempt status.OutcomeWe examined a single question regarding whether the
participant used the AUA CPG in clinical decision making.
Respondents could answer that they 1) use AUA clinical
guidelines in clinical decision making, or 2) do not use or
are not aware of AUA clinical guidelines.Predictor VariablesWe analyzed demographic characteristics including
age, race and ethnicity (white, nonwhite), Hispanic,
gender (male, female), AUA region (Southeastern, West-
ern, North Central, South Central, Mid-Atlantic, New
York, New England, Northeastern) and level of rurality
(metropolitan, nonmetropolitan). Gender and location
were collected from the National Provider Identiﬁer ﬁle
while all other participant information was self-reported
by respondents. We deﬁned levels of rurality using zip
codes that correspond to the rural-urban commuting areas
of the U.S. Census.11,12
Practice characteristics analyzed included work setting
(single urology group, academic, multispecialty group, solo
practice, public or private hospital, other) and provider
subspecialty (general, oncology, endourology/robotics,
pediatrics, sexual health/reconstruction, female pelvic
medicine).
464 Clinical Practice Guideline UseStatistical AnalysisAll data were analyzed with IBM SPSS Statistics soft-
ware version 23.0. The complex samples function in SPSS
was used to analyze complex survey samples to generate
representative data by specialty. These data were analyzed
with IBM SPSS Statistics 22 complex sample module to
account for the complex sample design. CSLOGICTIC
procedure was used to conduct multivariable logistic
regression analysis and determine odds ratios for each of the
practicing urologists’ characteristics on the likelihood that
CPG will be used in clinical decision making in a multi-
variate model. Taylor series linearization variances were
used to obtain correct standard errors and conﬁdence
intervals. Statistical signiﬁcance for all cases was deﬁned as
p 0.05.Table 1.
Demographics and practice settings of AUA census respondents
No. (%)
Age:
Less than 45 3,712 (31.7)
45e54 2,595 (22.2)
55e64 2,700 (23.1)
65 or Older 2,679 (22.9)
Race:
White 9,241 (83.4)
Nonwhite 1,840 (16.6)
Hispanic:
Yes 466 (4.1)
No 10,931 (95.9)
Gender:
Male 10,658 (91.1)
Female 1,045 (8.9)
AUA section:
Southeastern 2,476 (21.2)
Western 2,166 (18.5)
North Central 2,158 (18.4)
South Central 1,629 (13.9)
Mid-Atlantic 1,218 (10.4)
New York 893 (7.6)
New England 596 (5.1)
Northeastern 567 (4.8)
Level of rurality:
Metropolitan 10,387 (88.8)
Nonmetropolitan 1,316 (11.2)
Work setting:
Single urology group 4,029 (34.4)
Academic 2,679 (22.9)
Multispecialty group 2,031 (17.4)
Solo practice 1,444 (12.3)
Public or private hospital 1,292 (11.0)
Other 229 (2.0)
Subspecialty:
General 7,412 (63.3)
Oncology 1,337 (11.4)
Endourology/robotics 825 (7.0)
Pediatrics 702 (6.0)
Sexual health/male reconstruction 655 (5.6)
Female pelvic medicine 553 (4.7)Results
Weighted demographics for practicing U.S. urologists are
provided in table 1. Median age was 53 years with the age
group less than 45 having the highest representation. The
cohort consisted of predominately white (83.4%) men
(91.1%) The Southeastern section contributed the largest
proportion of urologists (21.2%), followed by the Western
(18.5%), North Central (18.4%), South Central (13.9%),Mid-
Atlantic (10.4%), New York (7.6%), New England (5.1%)
and Northeastern (4.8%) sections. Most respondents self-
identiﬁed as general urologists (63.3%), followed by sub-
specialization in oncology (11.4%), endourology/robotics
(7.0%), pediatrics (6.0%), sexual health/male reconstruction
(5.6%) and female pelvic medicine (4.7%).
The majority of urologists used CPG statements (94.8%)
in clinical decision making. Univariate analysis indicated
that urologists less than 45 years old were most likely to use
CPG (98.9%) while urologists 65 years old or older were
least likely (89.2%) (p <0.01, table 2). Race and ethnicity
did not inﬂuence CPG use while gender did. Women were
more likely to use guidelines than men (97.2% vs 94.6%,
p <0.01). Members of the New England section were most
likely to use CPGs (97.8%), while members of the New
York and Mid-Atlantic sections had the lowest use (92.6%
each, p <0.01). Urologists in metropolitan areas (94.6%)
were less likely to use CPGs than those in rural areas
(96.4%) (p¼0.006). Providers who worked in an academic
(96.9%) or public/private hospital (96.9%) had the highest
guideline use, followed by multispecialty group (95.5%),
single urology group (94.7%) and solo practice (88.3%)
(p <0.01). Practitioners trained in endourology/robotics
(98.2%) had the highest CPG use, followed by oncology
(97.8%), sexual health/reconstruction (95.1%), generalurology (94.5%), female pelvic medicine (93.1%) and
pediatrics (87.9%) (p <0.01).
In a multivariable model younger age increased the odds
of using CPGs (table 3). Those less than 45 years old had a
9.8 times greater odds of using CPGs compared to urologists
65 years old or older. Compared to solo practitioners,
urologists working at institutions had increased odds of
using CPGs (OR 2.58, 95% CI 1.40e4.76). Those working
in nonmetropolitan areas used the guidelines more (OR
2.47, 95% CI 1.12e5.47).Discussion
Among urologists who completed the AUA Census, the
majority use AUA CPGs in clinical decision making.
Table 2.
Demographics and practice settings of respondents who use AUA guidelines when making clinical decisions vs those who do not or are unaware
No. Use AUA Guidelines (%) No. Do Not Use AUA Guidelines (%) p Value
Age:
Less than 45 3,671 (98.9) 41 (1.1) <0.01
45e54 2,496 (96.2) 99 (3.8)
55e64 2,542 (93.5) 176 (6.5)
65 or Older 2,390 (89.2) 288 (10.8)
Race:
White 8,762 (94.8) 479 (5.2) 0.662
Nonwhite 1,741 (94.6) 100 (5.4)
Hispanic:
Yes 433 (92.9) 33 (7.1) 0.065
No 10,369 (94.9) 562 (5.1)
Gender:
Male 10,083 (94.6) 575 (5.4) <0.01
Female 1,016 (97.2) 29 (2.8)
AUA section:
Southeastern 2,300 (92.9) 175 (7.1) <0.01
Western 2,081 (96.0) 86 (4.0)
North Central 2,073 (96.1) 85 (3.9)
South Central 1,580 (97.0) 49 (3.0)
Mid-Atlantic 1,128 (92.6) 90 (7.4)
New York 827 (92.6) 66 (7.4)
New England 582 (97.8) 13 (2.2)
Northeastern 527 (93.1) 39 (6.9)
Level of rurality:
Metropolitan 9,830 (94.6) 557 (5.4) 0.006
Nonmetropolitan 1,269 (96.4) 47 (3.6)
Work setting:
Single urology group 3,813 (94.7) 215 (5.3) <0.01
Academic 2,596 (96.9) 83 (3.1)
Multispecialty group 1,939 (95.5) 92 (4.5)
Solo practice 1,275 (88.3) 169 (11.7)
Public or private hospital 1,251 (96.9) 40 (3.1)
Subspecialty:
General 7,007 (94.5) 406 (5.5) <0.01
Oncology 1,308 (97.8) 29 (2.2)
Endourology/robotics 810 (98.2) 15 (1.8)
Pediatrics 618 (87.9) 85 (12.1)
Sexual health/reconstruction 624 (95.1) 32 (4.9)
Female pelvic medicine 515 (93.1) 38 (6.9)
465Clinical Practice Guideline UseYounger urologists (less than 45 years old) constituted the
highest proportion of the cohort and also had the highest use
of CPG (98.9%). We saw the lowest use among the oldest
urologists, those in solo practice and those specializing in
pediatrics.
Nearly all younger practicing urologists use CPGs. This
may reﬂect exposure to CPGs during residency training and
awareness by urologists that CPGs contain material readily
testable on the various American Board of Urology certi-
fying examinations. Conversely, urologists age 65 or older
represented the lowest CPG use. This cohort includes
members who no longer need to take recertiﬁcation exam-
inations, which could inﬂuence CPG use. The overall high
rate of use in the entire cohort may be the result of educa-
tional efforts by the AUA and other organizations to pro-
mote CPG use, such as unveiling guidelines at the AUA
national and sectional meetings to increase exposure, as wellas other publicity efforts and multiple platforms to access
guidelines (handbooks, mobile applications, increased
exposure). Furthermore, increased interest in and awareness
of quality and safety metrics associated with pay-for-
performance established by payers may promote CPG
awareness.13
The study does have limitations. Our outcome is based on
a single item question. For respondents who provided a
negative response, it is unclear whether they were aware of
the clinical guidelines and chose not to use them, or if they
were unaware that the CPGs exist. The census also did not
ascertain use of guideline statements not produced by the
AUA that could be preferentially used by some urologists.
The accuracy of CPG use may be overinﬂated by social
disability bias.14 Respondents may have felt compelled to
answer the census CPG question in the afﬁrmative if they
were inﬂuenced by AUA sponsorship of the survey or
Table 3.
Multivariate associations among demographic, geographic and prac-
tice factors in using AUA guidelines when making clinical decisions
OR 95% CI
Age group:
Less than 45 9.88 4.06e24.07*
45e54 2.89 1.63e5.10*
55e64 1.56 0.96e2.54
65 or Older (baseline)
Work setting:
Single specialty 1.86 1.07e3.23*
Multispecialty 1.83 0.95e3.54
Institutions 2.58 1.40e4.76*
Solo (baseline)
Rurality:
Nonmetropolitan area 2.47 1.12e5.47*
Metropolitan area (baseline)
*p <0.05.
466 Clinical Practice Guideline Usecompleted the survey at the AUA annual meeting. While the
cohort sampled a large group of urologists, the results may
not be generalizable to all urologists. Finally, while CPG use
is high, this census question provides no detail regarding
guideline compliance or associated measures of quality.Conclusions
The majority of urologists (approximately 95%) use AUA
CPGs to inform clinical decisions. Older age, sub-
specialization and solo practice were associated with not
using or being aware of the guidelines. Our ﬁndings support
the importance of CPGs as a resource for urology practice
and highlight potential opportunities for better targeted
outreach to improve CPG use among practicing urologists.References
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hypothesis. Assessment 2017; 24: 746.Editorial CommentaryAUA clinical practice guidelines provide the framework for
managing a wide range of diseases through an evidence-
based review that is comprehensive and concise. For the
physician that means accessing reliable, up-to-date guide-
lines in a user-friendly format. However, the adoption of
CPGs in practice is variable and some have suggested there
is low adherence.1This study examined only a single question regarding
whether the AUA member used the AUA CPG in clinical
decision making. Respondents answered that they do use
AUA CPGs, or that they do not use them or are not aware of
them. So, while the good news is that the majority of
urologists surveyed use CPGs in decision making (94.8%),
we are left with many questions. For those who do use them,
467Clinical Practice Guideline Usethe extent and adherence to the treatment of patients on a
daily basis are largely unknown. And, for those who do not,
the barriers to adoption are not adequately known or
addressed.
The importance of a good understanding of CPGs is
evident in their use in board certiﬁcation and recertiﬁcation.
In addition, insurance providers have increasingly used
adherence to CPGs as part of quality metrics. Challenges for
the future include increasing the number of CPGs available
and updating prior CPGs to ensure the most contemporary
management is available. An additional barrier is deter-
mining the best way to disseminate the CPG so that these
guidelines will be widely available to clinicians regardless
of age, geographic setting or learning style. The furtherdevelopment of practice management tools such as registries
will allow us to measure adherence and track outcomes.
Michael S. Cookson
Department of Urology
University of Oklahoma
Oklahoma City, OklahomaReference
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2014; 12: 270.Reply by AuthorsWe appreciate the thoughtful comments made by Dr.
Cookson. We agree that our single question regarding the use
of CPGs leaves unaddressed the more important questions of
improving decision making and impacting patient outcomes.
Those answers will come, in part, from measures of imple-
mentation that may arise through integration into the elec-
tronic health record, in reductions in unnecessary testing, in
disease and patient reported outcomes, and costs of care. In
the coming years the AUA Quality (AQUA) Registry may
serve as a source to answer questions related to CPG use.
Continued attention to these important health services topics
by researchers and research funding agencies is paramount.
We laud the use of the AUA’s high level, scientiﬁcally
developed, up-to-date CPGs in postgraduate educationand certiﬁcations, and in the development of Choosing
Wisely statements. We support registries wholeheart-
edly. However, we are concerned about the adoption
of guideline statements into quality metrics as the
recommendation may not have been constructed to
adequately serve that purpose. The AUA Science and
Quality Council, of which the Quality Improvement and
Patient Safety Committee is an integral part, is working
on behalf of urologists to ensure that the federal and local
quality metrics are the best to measure quality of care,
cognizant that the ultimate impact of any clinical practice
guideline is at the level of the urologist and his/her
patient. Effectively engaging that dyad is paramount to all
that we do.
